Hecker & Associates

Hecker & Associates

Pharmaceuticals, 307 N Garfield St, Arlington, Virginia, 22201, United States, 1-10 Employees

hecker-associates.com

  • LinkedIn

Who is HECKER & ASSOCIATES

Hecker & Associates, LLC, is a drug development consulting group started in July 2001, strategizing for and managing production of global drug and biologic drug development projects, thro...

Read More

map
  • 307 N Garfield St, Arlington, Virginia, 22201, United States Headquarters: 307 N Garfield St, Arlington, Virginia, 22201, United States
  • 2001 Date Founded: 2001
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 8049 | NAICS Code: 455219 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from HECKER & ASSOCIATES

Hecker & Associates Org Chart and Mapping

Employees

Sandra Hecker

Regulatory Strategist, Us Agent, Regulatory Research Analyst

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Hecker & Associates

Answer: Hecker & Associates's headquarters are located at 307 N Garfield St, Arlington, Virginia, 22201, United States

Answer: Hecker & Associates's official website is https://hecker-associates.com

Answer: Hecker & Associates's revenue is Under $1 Million

Answer: Hecker & Associates's SIC: 8049

Answer: Hecker & Associates's NAICS: 455219

Answer: Hecker & Associates has 1-10 employees

Answer: Hecker & Associates is in Pharmaceuticals

Answer: Hecker & Associates contact info: Phone number: Website: https://hecker-associates.com

Answer: Hecker & Associates, LLC, is a drug development consulting group started in July 2001, strategizing for and managing production of global drug and biologic drug development projects, through cost- and time-efficient clinical trial and marketing applications. Sandy'smore than 20 years of pharmaceutical and biotech industry experience enables her to guide clients through the US and Canadian regulatory pathway appropriately and efficiently. Sandy identifies data and documentation "red-flags" before her client's submissions are filed, so the problems can be explained/eliminated, minimizing the number of regulatory agency questions about the application, assuring a good working relationship between her client and the regluatory agency, thus hastening the time to market for a successful drug. She has a special interest in helping companies implement and comply with the International Conference on Harmonisation (ICH) Common Technical Document (CTD) guidance and with INDs in electronic CTD format. Sandy also helps companies meet drug safety/pharmacovigilance requirements in the US, Canada, and Europe, as well as assists her clients assess potential new acquisitions, and out licensing opportunities through her regulatory "due diligence" work. In addition she supports a US immigration lawyer by writing "expert witness" letters for his clients who are in the pharmaceutical industry elsewhere in the world, and want to move to the United States.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access